Semiology and determinants of apathy across neurodegenerative motor disorders: A comparison between amyotrophic lateral sclerosis, Parkinson's and Huntington's disease

被引:2
|
作者
Poletti, Barbara [1 ]
Solca, Federica [1 ]
Maffi, Sabrina [2 ]
Torre, Silvia [1 ]
Carelli, Laura [1 ]
Aiello, Edoardo Nicolo [1 ,3 ]
Ferrucci, Roberta [4 ,5 ,6 ]
Priori, Alberto [4 ,5 ]
Monti, Alessia [7 ]
Verde, Federico [1 ,8 ]
Ticozzi, Nicola [1 ,8 ]
Migliore, Simone [2 ]
Scaricamazza, Eugenia [2 ]
Casella, Melissa [9 ]
Squitieri, Ferdinando [2 ]
Ciammola, Andrea [1 ]
Silani, Vincenzo [1 ,8 ]
机构
[1] IRCCS Ist Auxol Italiano, Dept Neurol & Lab Neurosci, Milan, Italy
[2] Fdn IRCCS Casa Sollievo Sofferenza Res Hosp, CSS Mendel Inst, Huntington & Rare Dis Unit, San Giovanni Rotondo, Italy
[3] Univ Milano Bicocca, Sch Med & Surg, PhD Program Neurosci, Monza, Italy
[4] Univ Milan, Aldo Ravelli Ctr Neurotechnol & Expt Brain Therape, Int Med Sch, Dept Hlth Sci, Milan, Italy
[5] San Paolo Univ Hosp, ASST Santi Paolo & Carlo, Milan, Italy
[6] IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Milan, Italy
[7] Casa Cura Policlin, Dept Neurorehabil Sci, Milan, Italy
[8] Univ Milan, Dino Ferrari Ctr, Dept Pathophysiol & Transplantat, Milan, Italy
[9] Italian League Res Huntington Fdn, Rome, Italy
来源
FRONTIERS IN AGING NEUROSCIENCE | 2022年 / 14卷
关键词
apathy; amyotrophic lateral sclerosis; Parkinson's disease; Huntington's disease; neuropsychology; COGNITIVE RESERVE; MULTIDIMENSIONAL APATHY; DIAGNOSTIC-CRITERIA; RATING-SCALE; VALIDATION; ALS; DEPRESSION; ANXIETY; PATHOPHYSIOLOGY;
D O I
10.3389/fnagi.2022.1031908
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
BackgroundThe semiology and determinants of apathy are largely unknown across amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Huntington's disease (HD), due to both motor and non-motor confounders. This study thus aimed at (1) profiling apathy in ALS, PD, and HD and (2) exploring its clinical determinants. MaterialsConsecutive ALS (N = 99), PD (N = 73), and HD (N = 25) patients underwent a motor-free assessment of apathy (Dimensional Apathy Scale, DAS), global cognition, anxiety and depression. Function was assessed through disease-specific scales. The DAS was also completed by N = 101 healthy controls (HCs). Between-group comparisons on DAS scores were implemented by covarying for all applicable confounders. Predictive models on DAS scores were built through multiple, stepwise regressions. ResultsParkinson's disease and HD, but not ALS, patients were more apathetic than HCs-with HD patients also selectively showing lower initiation and poorer goal-directed planning than HCs. Higher apathetic features were detected in PD and HD as compared to ALS. Education was a protective factor against apathy in ALS. Anxiety was a risk factor for global apathy in ALS, HD, and to a lesser extent, in PD, whereas, protective only toward affective disintegration in PD and ALS. Cognitive inefficiency was a risk factor toward apathy in both PD and ALS. Depression was a risk factor for executive-related apathy in PD. DiscussionThis study provides unprecedented insights into the heterogeneous semiology and determinants of apathy across ALS, PD, and HD via the DAS, in turn informing clinical practice and research.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Amyotrophic lateral sclerosis and Huntington's disease: Neurodegenerative link or coincidence?
    Chhetri, Suresh Kumar
    Dayanandan, Rejith
    Bindman, Dorothea
    Craufurd, David
    Majeed, Tahir
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2014, 15 (1-2) : 145 - 147
  • [2] Time series analysis of parkinson's disease, huntington's disease and amyotrophic lateral sclerosis
    Merrikh-Bayat, Farshad
    WORLD CONFERENCE ON INFORMATION TECHNOLOGY (WCIT-2010), 2011, 3
  • [3] Neurodegenerative disorders: Parkinson's disease and Huntington's disease
    Hague, SM
    Klaffke, S
    Bandmann, O
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (08): : 1058 - 1063
  • [4] Proteostasis and Movement Disorders: Parkinson's Disease and Amyotrophic Lateral Sclerosis
    Bosco, Daryl A.
    LaVoie, Matthew J.
    Petsko, Gregory A.
    Ringe, Dagmar
    COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2011, 3 (10): : 1 - 24
  • [5] Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis)
    Gaggelli, Elena
    Kozlowski, Henryk
    Valensin, Daniela
    Valensin, Gianni
    CHEMICAL REVIEWS, 2006, 106 (06) : 1995 - 2044
  • [6] Huntington's disease presenting as amyotrophic lateral sclerosis
    Phukan, Julie
    Ali, Elfatih
    Pender, Niall P.
    Molloy, Fiona
    Hennessy, Michael
    Walsh, Ronan J.
    Hardiman, Orla
    AMYOTROPHIC LATERAL SCLEROSIS, 2010, 11 (04): : 405 - 407
  • [8] Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis
    Ambegaokar, Surendra S.
    Roy, Bidisha
    Jackson, George R.
    NEUROBIOLOGY OF DISEASE, 2010, 40 (01) : 29 - 39
  • [9] Conservative iron chelation for neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis
    David Devos
    Z. Ioav Cabantchik
    Caroline Moreau
    Véronique Danel
    Laura Mahoney-Sanchez
    Hind Bouchaoui
    Flore Gouel
    Anne-Sophie Rolland
    James A. Duce
    Jean-Christophe Devedjian
    Journal of Neural Transmission, 2020, 127 : 189 - 203
  • [10] Iron as a therapeutic target for neurodegenerative diseases (Parkinson's disease and amyotrophic lateral sclerosis)
    Devos, D.
    Moreau, C.
    FEBS OPEN BIO, 2018, 8 : 33 - 33